NeurotechMagProGet access
Funding Round

Helius Medical raises $18M to fund VA national formulary rollout for PoNS TBI therapy

Helius Medical Investor Relations4/23/2026ยท04/23/26๐ŸŒ USA

Summary

Helius Medical completed an $18M private placement to fund commercial infrastructure for rollout of the PoNS device across VA medical centers following National Formulary listing. Funds support clinical training programs for VA therapists, patient support services, and studies of PoNS in blast-induced TBI โ€” the most common injury type in combat veterans.

Why it matters

VA National Formulary listing de-risked Helius' commercial model by guaranteeing a large, defined patient population. The $18M raise is sized specifically for execution, not further R&D โ€” a disciplined approach signaling the commercial phase is underway.

#Industry#Neurostimulation#TBI#USA#Venture Capital

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in